Skip to content

Clinical trials

Phase 2 Uterine Cervical Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 2 Clear all

418 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20015
20026
20037
200411
200512
200613
200713
200810
200915
20104
201110
20128
20135
20147
201514
20165
201713
201820
201915
202022
202132
202222
202325
202431
202536
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150
Unknown status76
Recruiting69
Terminated40
Not yet recruiting38
Active, not recruiting24
Withdrawn19
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)26
Gynecologic Oncology Group23
Lei Li8
M.D. Anderson Cancer Center8
Merck Sharp & Dohme LLC7
Peking Union Medical College Hospital7
Sun Yat-sen University6
Cancer Institute and Hospital, Chinese Academy of Medical Sciences5
Fujian Cancer Hospital5
Tianjin Medical University Cancer Institute and Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms418
Endometrial Neoplasms51
Ovarian Neoplasms44
Vulvar Neoplasms29
Vaginal Neoplasms26
Carcinoma, Non-Small-Cell Lung24
Breast Neoplasms22
Esophageal Neoplasms18
Neoplasms17
Colorectal Neoplasms16

Trials

Showing 26 to 50 of 418. Each trial links to its page on Pharma Observatory.

318 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.